• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Avedro, Inc., an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations. Its Avedro Corneal Remodeling platform treats corneal ectatic disorders and corrects refractive conditions; and KXL system in combination with Photrexa drug formulations used for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Avedro sells its products primarily to ophthalmologists, hospitals, and ambulatory surgery centers through a direct sales force in the United States, as well as through medical device distributors internationally. The company was formerly known as ThermalVision, Inc. and changed its name to Avedro, Inc. in October 2005. Avedro, Inc. was incorporated in 2002 and is headquartered in Waltham, Massachusetts.
| Market Cap | 394.049 Million | Shares Outstanding | 17.14 Million | Avg 30-day Volume | 92.044 Thousand |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.52 |
| Price to Revenue | 0.0 | Debt to Equity | 0.9294 | EBITDA | 0 |
| Price to Book Value | 9.0197 | Operating Margin | 0.0 | Enterprise Value | 732.13 Million |
| Current Ratio | 16.817 | EPS Growth | 0 | Quick Ratio | 15.013 |
| 1 Yr BETA | 1.7175 | 52-week High/Low | 0.0 / | Profit Margin | 0.0 |
| Operating Cash Flow Growth | 0.0 | Altman Z-Score | 17.6759 | Free Cash Flow to Firm | 0 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
No longer subject to file | 2019-11-21 | 0 | |
|
No longer subject to file | 2019-11-21 | 0 | |
|
No longer subject to file | 2019-11-21 | 0 | |
|
No longer subject to file | 2019-11-21 | 0 | |
|
SCHUERMANN JAMES CHIEF BUSINESS OFFICER |
|
No longer subject to file | 2019-11-21 | 0 |
|
No longer subject to file | 2019-11-21 | 0 | |
|
BAVIER PAUL S GENERAL COUNSEL AND SEC. |
|
No longer subject to file | 2019-11-21 | 0 |
|
GRIFFIN THOMAS E CHIEF FINANCIAL OFFICER |
|
No longer subject to file | 2019-11-21 | 0 |
|
ZADNO REZA PRESIDENT AND CEO |
|
No longer subject to file | 2019-11-21 | 0 |
|
FIRST DAVID CHIEF HUMAN RESOURCES OFFICER |
|
No longer subject to file | 2019-11-21 | 0 |
|
RAJPAL RAJESH K. CHIEF MEDICAL OFFICER |
|
No longer subject to file | 2019-11-21 | 0 |
|
No longer subject to file | 2019-11-21 | 0 | |
|
0 | 2019-06-14 | 0 | |
|
0 | 2019-06-14 | 0 | |
|
4,240,128 | 2019-02-19 | 0 | |
|
2,742,239 | 2019-02-19 | 0 | |
|
109,534 | 2019-02-13 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
